Related Experiment Video
Updated: Feb 5, 2026

An In Vitro Approach to Study Mitochondrial Dysfunction: A Cybrid Model
Published on: March 9, 2022
Mitochondrial dysfunction caused by m.2336T>C mutation with hypertrophic cardiomyopathy in cybrid cell lines
Dan Li1, Yaping Sun2, Qianqian Zhuang2
1College of Life Science, Zhejiang University, Hangzhou, Zhejiang 310058, China; Department of Urology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266003, China.
Insights
A novel mitochondrial DNA mutation (m.2336T>C) impairs mitochondrial function, leading to cellular dysfunction and reduced survival. This finding suggests a role for this mutation in hypertrophic cardiomyopathy (HCM) pathogenesis.
Area of Science:
- Genetics
- Cardiology
- Mitochondrial Biology
Background:
- Hypertrophic cardiomyopathy (HCM) is a leading cause of sudden cardiac death in young individuals.
- Mitochondrial DNA (mtDNA) mutations are implicated as a primary cause of HCM.
- A specific m.2336T>C mutation in the MT-RNR2 gene was identified in a Chinese HCM family.
Purpose of the Study:
- To elucidate the molecular mechanisms underlying the contribution of the m.2336T>C mutation to HCM.
- To investigate the functional consequences of the m.2336T>C mutation on mitochondrial function.
Main Methods:
- Generation of transmitochondrial cell lines (cybrids) with a consistent nuclear background.
- Transfer of mitochondria carrying the m.2336T>C mutation into human mtDNA-less (ρ°) cells.
- Functional assays to assess mitochondrial stability, translation capacity, ROS generation, ATP production, and membrane potential.
Main Results:
- The m.2336T>C mutation led to decreased 16S rRNA stability and reduced levels of its binding proteins.
- Impaired mitochondrial translation capacity, elevated ROS production, and reduced ATP synthesis were observed.
- Mutant cybrids exhibited diminished mitochondrial membrane potential, poor physiological status, and decreased survival.
Conclusions:
- The m.2336T>C mutation directly causes significant mitochondrial dysfunction.
- These findings strongly suggest that the m.2336T>C mutation plays a role in the pathogenesis of hypertrophic cardiomyopathy (HCM).
Abstract:
Hypertrophic cardiomyopathy (HCM), affecting approximately 1 in 500 in the general population, is the most prominent cause of sudden heart disease-related mortality in the young. Mitochondrial DNA (mtDNA) mutations are among the primary causes of HCM. We previously identified a novel m.2336T>C homoplasmic mutation in the mitochondrial 16S rRNA gene (MT-RNR2) in a Chinese maternally inherited HCM family. However, the molecular mechanisms by which m.2336T>C mutation contributes to HCM remain elusive. Here we generated transferring mitochondria cell lines (cybrids) with a constant nuclear background by transferring mitochondria from immortalized lymphoblastoid cell lines carrying the HCM-associated m.2336T>C mutation into human mtDNA-less (ρ°) cells. Functional assays showed a decreased stability for 16S rRNA and the steady-state levels of its binding proteins in the mutant cybrids. This mutation impaired the mitochondrial translation capacity and resulted in many mitochondrial dysfunctions, including elevation of ROS generation, reduction of ATP production and impairment of mitochondrial membrane potential. Moreover, the mutant cybrids had poor physiological status and decreased survival ability. These results confirm that the m.2336T>C mutation leads to mitochondrial dysfunction and strongly suggest that this mutation may play a role in the pathogenesis of HCM.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Export of Mitochondrial and Chloroplast Genes
Animal Mitochondrial Genetics
Cardiomyopathy II: Dilated Cardiomyopathy

